FDA WARNING_LETTER - Newhere Inc dba CBDFX - November 21, 2022

FDA WARNING_LETTER for Newhere Inc dba CBDFX on November 21, 2022. Product: Food. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Newhere Inc dba CBDFX on November 21, 2022. Product: Food. Access full analysis and detailed observations.

Violation Codes

21 U.S.C. 360b(a)

21 U.S.C. 331(d)

21 U.S.C. 348(a)

21 U.S.C. 321(p)

21 U.S.C. 331(a)

21.U.S.C. 355(a)

21 CFR 181

21 U.S.C. 355

21 U.S.C. 331(ll)

21 CFR 570.30

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Newhere Inc dba CBDFX

Inspection Date

November 21, 2022

Product Type

Food

Office

Center for Food Safety and Applied Nutrition

People

ID: 2a7b5714-4c0b-475d-a86d-db9dc83ae66c

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox